HCV RNA quantitative real time PCR is a laboratory test that detects and measures hepatitis C virus genetic material (RNA) in blood. It uses reverse transcription followed by PCR with fluorescent probes to quantify viral load (copies/mL). Clinically it confirms active infection, guides treatment choice and duration, monitors antiviral response, and checks for sustained virologic response or relapse after therapy.

The HCV RNA PCR test detects hepatitis C virus genetic material (RNA) to confirm active infection and quantify viral load. It can identify infection before antibodies appear, guide treatment choices and timing, monitor antiviral therapy effectiveness, and verify cure after treatment (sustained virologic response). Results inform clinicians about treatment need, response, and risk of ongoing liver damage.

A positive HCV PCR test means hepatitis C virus RNA was detected in your blood, indicating an active infection (either recent/acute or chronic). It confirms current viral replication rather than past exposure. Next steps typically include liver function tests, viral load and genotype assessment, evaluation for treatment, and counselling on transmission prevention. Many effective antiviral treatments can cure HCV in most people.

Normal (negative) HCV RNA is "undetectable"—below the assay’s lower limit of detection. Modern quantitative PCR assays typically consider <15 IU/mL (some report <12–15 IU/mL) as undetectable; older tests used <50 IU/mL. Any value above the assay-specific lower limit indicates measurable viremia and should be interpreted with clinical context and follow-up testing.

If an HCV test is positive, you’ll get a confirmatory HCV RNA test and liver evaluation (blood tests, imaging, fibrosis assessment). A specialist will recommend direct-acting antiviral treatment, which cures most people. You’ll be advised on preventing transmission (avoid sharing needles, practice safer sex), offered hepatitis A/B vaccination if needed, and monitored for liver damage and treatment response.

HCV refers to the hepatitis C virus or, in testing, anti‑HCV antibodies indicating exposure. An HCV RNA test detects the virus’s genetic material, confirming active infection and measuring viral load. RNA appears earlier after infection and distinguishes current replication from past, treated, or cleared infection—so antibody positive plus RNA negative means past/resolved infection, while RNA positive indicates ongoing infection.